The evolution of insulin therapy: innovations, challenges, and future prospects is reshaping diabetes management, offering improved formulations and delivery systems. Ultra-rapid and ultra-long-acting insulins provide greater flexibility, reducing the risk of hypoglycemia while optimizing glucose control. Smart insulin pens and continuous glucose monitoring integration enhance precision in dosing. However, challenges such as cost, adherence, and weight gain remain significant barriers to widespread adoption. Research is advancing toward glucose-responsive insulins and implantable delivery systems that mimic pancreatic function. As personalized medicine continues to drive innovation, novel insulin analogs and alternative routes of administration, including oral and inhaled formulations, hold promise for the future of diabetes treatment.
Title : Adipose MTP deficiency protects against hepatic steatosis by upregulating PPAR activity
Sujith Rajan, NYU Long Island School of Medicine, United States
Title : Important roles and mechanisms of novel calcium signaling in diabetes-induced vascular dementia
Yong Xiao Wang, Albany Medical College, United States
Title : Does winter melon (Benincasa hispida) improves nutritional values and ameliorating glycaemic parameters?
Wan Rosli Wan Ishak, Universiti Sains Malaysia, Malaysia
Title : Diabetes reduction (pre-diabetes and type 2) with integrative medicine
F Buck Willis, Belize Bible College, Belize
Title : The menopausal mind: Reframing female senescence as a neuroendocrine disorder with root cause management strategies
Amy Gutman, AdventHealth; Tough Love MD, United States
Title : Bridging the gap: Coaching patients on GLP-1s for sustainable outcomes beyond the prescription
Keith Hersey, Master Your GLP-1, United States